scholarly article | Q13442814 |
P356 | DOI | 10.1136/ARD.2007.078832 |
P698 | PubMed publication ID | 17965124 |
P50 | author | Rene E Toes | Q42494390 |
Annette H. van der Helm-van Mil | Q67408980 | ||
P2093 | author name string | Huizinga TW | |
Allaart CF | |||
van der Kooij SM | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 769-774 | |
P577 | publication date | 2007-10-26 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis | |
P478 | volume | 67 |
Q47772154 | A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs |
Q45787030 | A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis |
Q93054220 | A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases |
Q33950766 | Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. |
Q37380362 | Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis |
Q47734526 | Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions |
Q47325126 | Are obesity and rheumatoid arthritis interrelated? |
Q57788293 | Association of High Body Mass Index With Decreased Treatment Response to Combination Therapy in Recent-Onset Rheumatoid Arthritis Patients |
Q47885394 | Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. |
Q64119496 | Associations between Adipokines in Arthritic Disease and Implications for Obesity |
Q39710835 | Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis |
Q33632098 | Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis |
Q58234801 | Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis |
Q38763702 | Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations |
Q51013068 | Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). |
Q37358808 | Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons |
Q39296233 | Body mass index and response to abatacept in rheumatoid arthritis |
Q87142111 | Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study |
Q36198718 | Body mass index and the rheumatoid arthritis swollen joint count: an observational study |
Q39164961 | Can Rheumatologists Predict Eventual Need for Orthopaedic Intervention in Patients with Rheumatoid Arthritis? Results of a Systematic Review and Analysis of Two UK Inception Cohorts |
Q28082992 | Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? |
Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
Q39993473 | Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis |
Q92224136 | Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis |
Q36999878 | Contribution of obesity to the rise in incidence of rheumatoid arthritis |
Q99630709 | Effect of Body Mass Index on the Disease Activity of Patients With Rheumatoid Arthritis in a Gender-Specific Manner and the Association of Respective Serum C-Reactive Protein Levels With the Body's Inflammatory Status |
Q34189534 | Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats. |
Q92542142 | Fat-Produced Adipsin Regulates Inflammatory Arthritis |
Q34330638 | Fatty acids, lipid mediators, and T-cell function |
Q48338337 | Functional and phenotypical analysis of IL-6-secreting CD4+ T cells in human adipose tissue |
Q34450993 | Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study |
Q36732733 | Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years |
Q38767940 | Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts |
Q36326901 | Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis |
Q33750548 | Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis |
Q34089998 | Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. |
Q36297290 | Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients |
Q45953403 | Lack association of body mass index with disease activity composites of rheumatoid arthritis in Korean population: cross-sectional observation. |
Q33575341 | Lack of association of high body mass index with risk for developing polymyalgia rheumatica |
Q26822038 | Metabolic syndrome in rheumatoid arthritis |
Q64229233 | Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study |
Q89099319 | Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National Registry |
Q36120756 | Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation |
Q26778275 | Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response |
Q89523046 | Obesity and its role in the management of rheumatoid and psoriatic arthritis |
Q34488394 | Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). |
Q37801496 | Obesity in rheumatoid arthritis |
Q44368185 | Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis |
Q48874324 | Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients |
Q64125008 | Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis |
Q92003457 | Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis |
Q46176650 | Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis. |
Q35065164 | Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage? |
Q36784187 | Predictors of longterm changes in body mass index in rheumatoid arthritis |
Q51333035 | Predictors of severe radiographic progression in patients with early rheumatoid arthritis: A Prospective observational cohort study. |
Q39091655 | Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features |
Q47202397 | Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies |
Q38569273 | Response to 'Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis'. |
Q37385755 | Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases |
Q38236740 | Rheumatoid arthritis and metabolic syndrome |
Q37774545 | Rheumatoid cachexia and cardiovascular disease. |
Q51187397 | Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. |
Q64982546 | Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. |
Q37690729 | Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort |
Q55267199 | Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis. |
Q58042690 | Systemic disease sequelae in chronic inflammatory diseases and chronic psychological stress: comparison and pathophysiological model |
Q28074864 | The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care |
Q34139272 | The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis |
Q36000249 | The challenging interplay between rheumatoid arthritis, ageing and comorbidities |
Q36148660 | Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis |
Q51667223 | Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. |
Q35045933 | Utility of different cardiovascular disease prediction models in rheumatoid arthritis |
Q64078464 | Vitamin D Receptor Gene Polymorphism: An Important Predictor of Arthritis Development |
Search more.